PharmaEssentia

An artists depiction of different types of blood cells from bone marrow
Pharma

PharmaEssentia plots expansion for blood cancer med Besremi

PharmaEssentia looks to file Besremi for a label expansion in essential thrombocythemia with the FDA by the end of 2025.
Zoey Becker Jan 7, 2025 9:00am
artery blood vessel plaque cholesterol

PharmaEssentia nabs MorphoSys alum for CCO role

Dec 6, 2024 9:48am
The logo for PharmaEssentias PVME campaign

PharmaEssentia shares rare blood cancer stories in video series

Sep 19, 2023 9:45am
Man and woman having coffee outside

New Besremi campaign focuses on what counts

Feb 24, 2023 8:20am
FDA Building 2

PharmaEssentia gains FDA approval for rare blood cancer drug

Nov 15, 2021 9:02am
FDA Building 2

FDA rejects rare disease drug, asks for prefilled syringe info

Mar 16, 2021 10:30am